Medtronic

By Laura Lovett 11:59 am September 1, 2020
Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 diabetes.  This clearance means that the tool can be marketed to children as young as 2. It can also be used for adults. The system includes an algorithm which is able to measure a patient’s glucose...
By Laura Lovett 11:26 am August 11, 2020
This morning medical device company Medtronic announced its plans to buy Companion Medical, which is best known for making the InPen, an insulin pen that integrates a companion app, for an undisclosed sum.  Companion Medical has been in the digital health game for some time. Its InPen fist scored FDA clearance in 2016 and its funding round attracted the likes of pharma giant Eli Lilly. The...
By Dave Muoio 02:37 pm June 15, 2020
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts. Onduo Verily-backed diabetes management service Onduo, which combines a mobile app...
By MobiHealthNews 03:11 pm February 18, 2020
Lumeon, a digital health startup that employs automation to help with operational functions, has inked a deal with the Mayo Clinic. As part of the deal, the Mayo Clinic’s library of clinical insights will be integrated into Lumeon’s Care Pathway Management Platform.  “Mayo Clinic is not only one of the most prestigious health systems in the world, but they have also been an early adopter of...
By Sophie Porter 11:10 am February 18, 2020
US medical technology provider Medtronic has announced the acquisition of Digital Surgery, a UK-based company specialising in surgical AI and digital education and training. The purchase integrates Digital Surgery into Medtronic’s Surgical Robotics business, a subset of their Minimally Invasive Therapies Group. WHY IT MATTERS Medtronic is the largest medical device supplier in the world. By...
By Jonah Comstock 11:33 am December 17, 2019
Dublin-based medical technology company Medtronic has acquired digital health startup Klue, a two-year-old startup which uses gesture sensing and other behavioral health metrics to determine when someone is eating. Nothing was disclosed about the terms of the deal, except that Medtronic considers it to be immaterial to 2020 earnings per share. "Bringing Klue and their unique meal detection...
By Dave Muoio 03:32 pm October 31, 2019
Apple's high on health. Apple CEO Tim Cook was pleased as punch with his company’s latest quarterly and yearly report, which he said on an investor’s call yesterday was Apple’s “highest revenue in a September quarter ever” at $64 billion. Thirty-three million dollars of this was in iPhone revenue — a 9% decline over last year that he felt was a significant step up from the 15% decline seen...
By Laura Lovett 03:58 pm July 25, 2019
Healthcare artificial intelligence company Viz.ai announced that it is joining forces with Medtronic with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US.  “Medtronic is an innovative company focused on therapies that extend life and...
By Dave Muoio 04:03 pm June 10, 2019
On Friday, the American Diabetes Association kicked off its annual conference in San Francisco, where academics, vendors and other stakeholders congregated to unveil new study results and major announcements related to diabetes management. And while MobiHealthNews already put together a roundup featuring an opening salvo of the show’s announcements, the past few days have seen a tidal wave of new...
By Dave Muoio 02:55 pm May 28, 2019
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range. Collected from nearly 8 million days of recorded system use and announced by Medtronic today in a press release, the new findings also suggest that this rate increased further for those who employed...